Peter Attia· MD
From a solid organ metastatic perspective, from 74 until 10 years ago. Isn't testicular the only success, maybe, and GIST? Yeah.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
From a solid organ metastatic perspective, from 74 until 10 years ago. Isn't testicular the only success, maybe, and GIST? Yeah.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
there's those Niche examples I gave you testicular cancer is now an exception um G IST stromal tumors would be an exception and I'm not including leukemias and and lymphomas where now there are exceptions